Active Ingredient History
Berberine is a quaternary ammonium salt from the protoberberine group of benzylisoquinoline alkaloids, occurring naturally as a secondary metabolite in some plants including species of Berberis, from which its name is derived. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenocarcinoma of Lung (Phase 2)
Adolescent (Phase 2)
Atherosclerosis (Phase 4)
Atrophy (Phase 3)
Berberine (Phase 4)
Bile Duct Diseases (Phase 2)
Biliary Tract Diseases (Phase 2)
Blood Pressure (Phase 4)
Cholangitis (Phase 2)
Cholangitis, Sclerosing (Phase 2)
Cholestasis (Phase 2)
Colitis, Ulcerative (Phase 4)
Colorectal Neoplasms (Phase 2/Phase 3)
Coronary Artery Disease (Phase 4)
COVID-19 (Phase 4)
Cyclosteroids (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 3)
Digestive System Diseases (Phase 2)
Diverticulitis (Phase 2)
Drugs, Investigational (Early Phase 1)
Dyslipidemias (Phase 4)
Dyspepsia (Phase 4)
Endothelial Cells (Phase 4)
Esophageal and Gastric Varices (Phase 3)
Gastritis (Phase 4)
Glucose Intolerance (Phase 4)
Heart Disease Risk Factors (Phase 2/Phase 3)
Helicobacter pylori (Phase 4)
Hepatitis B (Phase 3)
Hepatitis C, Chronic (Phase 3)
HIV Infections (Phase 3)
Hypercholesterolemia (Phase 4)
Hyperglycemia (Phase 4)
Hyperlipidemias (Phase 2/Phase 3)
Hypertension (Phase 4)
Inflammation (Phase 4)
Lipodystrophy (Phase 3)
Lipoproteins (Phase 2/Phase 3)
Liver Cirrhosis, Biliary (Phase 2)
Malabsorption Syndromes (Phase 1)
Malnutrition (Phase 3)
Mesothelioma, Malignant (Phase 2)
Metabolic Syndrome (Phase 4)
Metformin (Phase 4)
Mutation (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 4)
Obesity (Phase 4)
Obesity, Abdominal (Phase 4)
Oxidative Stress (Phase 3)
Peptic Ulcer (Phase 4)
Percutaneous Coronary Intervention (Phase 4)
Prediabetic State (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Schizophrenia (Phase 4)
Schizophrenia Spectrum and Other Psychotic Disorders (Phase 2/Phase 3)
Stomach Neoplasms (Phase 4)
Stomach Ulcer (Phase 4)
Therapeutics (Phase 4)
Triglycerides (Phase 2/Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue